Bartter syndrome screening: Difference between revisions
Jump to navigation
Jump to search
TayyabaAli (talk | contribs) |
TayyabaAli (talk | contribs) |
||
| Line 6: | Line 6: | ||
==Screening== | ==Screening== | ||
*[[Genetic screening]] for [[Bartter syndrome]] | *[[Genetic screening]] for [[Bartter syndrome]] mutated genes can be performed among individuals with unexplained [[hypertension]] and [[hypokalemia]].<ref name="pmid29953267">{{cite journal| author=Bao M, Cai J, Yang X, Ma W| title=Genetic screening for Bartter syndrome and Gitelman syndrome pathogenic genes among individuals with hypertension and hypokalemia. | journal=Clin Exp Hypertens | year= 2019 | volume= 41 | issue= 4 | pages= 381-388 | pmid=29953267 | doi=10.1080/10641963.2018.1489547 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29953267 }} </ref> | ||
*There is an insufficient evidence to recommend routine [[screening]] for [[Bartter syndrome]]. | *There is an insufficient evidence to recommend routine [[screening]] for [[Bartter syndrome]]. | ||
==References== | ==References== | ||
Latest revision as of 12:48, 7 August 2020
Main article: Bartter syndrome
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Tayyaba Ali, M.D.[2]
Overview
Genetic screening for Bartter syndrome mutated genes can be performed among individuals with unexplained hypertension and hypokalemia.
Screening
- Genetic screening for Bartter syndrome mutated genes can be performed among individuals with unexplained hypertension and hypokalemia.[1]
- There is an insufficient evidence to recommend routine screening for Bartter syndrome.
References
- ↑ Bao M, Cai J, Yang X, Ma W (2019). "Genetic screening for Bartter syndrome and Gitelman syndrome pathogenic genes among individuals with hypertension and hypokalemia". Clin Exp Hypertens. 41 (4): 381–388. doi:10.1080/10641963.2018.1489547. PMID 29953267.